News

T-bet is a transcription factor, one of the control proteins in the cell nucleus that can turn specific groups of genes on ...
At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...
Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...
Teclistamab-cqyv (Tecvayli) led to clinically meaningful responses in patients with heavily pretreated multiple myeloma who ...
This new article publication from Acta Pharmaceutica Sinica B, discusses how melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 ...
Learn more about the research of Mayo Clinic's Gene Editing and Cellular Engineering Laboratory led by David (Chun-Wei) D.
Lisocabtagene maraleucel delivers sustained survival benefits and long-term disease control in relapsed or refractory LBCL.
There are few scientific methods more elegantly simple than "just sprinkle it on top." Researchers at Tohoku University and ...